Dr. Stewart Sell Wins ISOBM-Abbott Award
Dr. Stewart Sell, a member of BioCurex's Scientific Advisory Board, has been awarded the prestigious ISOBM-Abbott award for his lifetime achievements in cancer research, immunology, developmental biology, and stem cell research. Dr. Sell's achievements go beyond research, since he is an excellent pathologist and a gifted teacher who has written text books that are currently used by medical students. He received a special award for 25 years of teaching cancer biology by the American Association of Cancer Research (AACR). Dr. Sell has published over 350 scientific papers and 14 books. In 1984 his paper on activation of lymphocytes by reaction of ligands with surface immunoglobulin was listed as a Citation Classic. He has been named both a Distinguished Alumnus of the School of medicine (Hench Award) and a Legacy Laureate of the University of Pittsburgh (the highest honor for a Pitt graduate). In 1998 he was cited as a Distinguished Scientist by the IATMO. In 2005, he received the Rudolf Virchow Award (LeadershipMedica, Italy) and in 2007, his paper on cancer stem cells was cited as a Scientific Landmark publication by AACR.

Dr. Sell (right) receiving the ISOBM-Abbott award from Dr. Robert Doss representing Abbott (middle) and Dr. Torgny Stigbrand, President of ISOBM.
PrimeZone Media Network, Inc.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.